Erratum {#Sec1}
=======

While compiling this article \[[@CR1]\] one of the authors was inadvertently omitted from the author list. This author, The Canadian Critical Care Trials Group (CCCTG), has been included in the corrected author list above.

The online version of the original article can be found under doi:10.1186/1741-7015-12-74.
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